HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radiation dose and risk from fluoroscopically guided percutaneous transluminal angioplasty and stenting in the abdominal region.

Abstract
The objective of this study was to estimate the radiation dose and associated risks resulting from fluoroscopically guided percutaneous transluminal angioplasty with or without stent placement in the abdominal region. Average examination parameters for renal and aortoiliac procedures were derived using data from 80 consecutive procedures performed in our institute. Organ and effective doses were estimated for endovascular procedures with the use of a Monte Carlo (MC) transport code and an adult mathematical phantom. Thermoluminescent dosimeters were used in an anthropomorphic phantom to verify MC calculations. Radiation-induced risks were estimated. Results are presented as doses normalized to dose area product, so that the patient dose from any technique and X-ray unit can be easily calculated for iliac and renal PTA/stenting sessions. The average effective dose varied from 75 to 371 microSv per Gycm(2) depending on the beam quality, procedure scheme and sex of the patient. Differences up to 17% were observed between MC-calculated data and data derived from thermoluminescent dosimetry. The radiation-induced cancer risk may be considerable for younger individuals undergoing transluminal angioplasty with stent placement.
AuthorsJohn Stratakis, John Damilakis, Dimitrios Tsetis, Nicholas Gourtsoyiannis
JournalEuropean radiology (Eur Radiol) Vol. 17 Issue 9 Pg. 2359-67 (Sep 2007) ISSN: 0938-7994 [Print] Germany
PMID17387479 (Publication Type: Journal Article)
Topics
  • Angioplasty
  • Fluoroscopy (adverse effects)
  • Humans
  • Monte Carlo Method
  • Peripheral Vascular Diseases (diagnostic imaging, therapy)
  • Phantoms, Imaging
  • Radiation Dosage
  • Radiography, Abdominal (adverse effects)
  • Radiography, Interventional (adverse effects)
  • Renal Artery Obstruction (diagnostic imaging, therapy)
  • Risk Assessment
  • Statistics, Nonparametric
  • Stents
  • Thermoluminescent Dosimetry

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: